Fatal acute haemopericardium associated with rivaroxaban in a patient with non-valvular atrial fibrillation

被引:0
|
作者
Omer, Siddiq [1 ]
Magezi, Frederick [2 ]
Patel, Martyn [3 ]
Alsawaf, Ali [4 ]
机构
[1] James Paget Univ Hosp, ST4 Geriatr, Great Yarmouth, England
[2] Queen Elizabeth Hosp, ST4 Geriatr, Kings Lynn, England
[3] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
[4] Queen Elizabeth Hosp, Kings Lynn, England
关键词
Rivaroxiban; Haemopericardium; Fatal; Older people;
D O I
10.1093/ageing/afz070
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
An 82-year-old female was admitted with chest pain and non-specific T wave changes on her ECG. After 72 hours of conservative management she deteriorated with non-specific symptoms including nausea and a single episode of vomiting. Abdominal and Chest X-rays were unremarkable, blood tests showed worsening Acute Kidney Injury (AKI) on Chronic Kidney Disease (CKD); and raised C-Reactive Protein (CRP) with no obvious symptoms or focus of infection. She rapidly deteriorated going into asystole cardiac arrest and attempts at resuscitation failed. Post-mortem examination suggested the most likely cause of death was acute spontaneous Haemopericardium due to Rivaroxaban therapy which she was on for non-valvular Atrial Fibrillation (AF). We believe that this might be the first reported mortality with Rivaroxaban-associated spontaneous haemopericardium in the UK.
引用
收藏
页码:758 / 760
页数:3
相关论文
共 50 条
  • [21] Elevated levels of RDW is associated with non-valvular atrial fibrillation
    Barış Güngör
    Kazım Serhan Özcan
    İzzet Erdinler
    Ahmet Ekmekçi
    Ahmet Taha Alper
    Damirbek Osmonov
    Nazmi Çalık
    Sukru Akyuz
    Ercan Toprak
    Hale Yılmaz
    Aydın Yıldırım
    Osman Bolca
    [J]. Journal of Thrombosis and Thrombolysis, 2014, 37 : 404 - 410
  • [22] Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in Chinese patients with non-valvular atrial fibrillation
    Liu, Xiao-qin
    Zhang, Yu-fei
    Ding, Hong-yan
    Yan, Ming-ming
    Jiao, Zheng
    Zhong, Ming-kang
    Ma, Chun-lai
    [J]. ACTA PHARMACOLOGICA SINICA, 2022, 43 (10) : 2723 - 2734
  • [23] The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation
    Shimokawa, Hiroaki
    Yamashita, Takeshi
    Uchiyama, Shinichiro
    Kitazono, Takanari
    Shimizu, Wataru
    Ikeda, Takanori
    Kamouchi, Masahiro
    Kaikita, Koichi
    Fukuda, Koji
    Origasa, Hideki
    Sakuma, Ichiro
    Saku, Keijiro
    Okumura, Yasuo
    Nakamura, Yuichiro
    Morimoto, Hideo
    Matsumoto, Naoki
    Tsuchida, Akihito
    Ako, Junya
    Sugishita, Nobuyoshi
    Shimizu, Shogo
    Atarashi, Hirotsugu
    Inoue, Hiroshi
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 258 : 126 - 132
  • [24] Safe chest tube placement in a patient with tension pneumothorax receiving rivaroxaban therapy for non-valvular atrial fibrillation
    Cipriano, Alessandro
    Parollo, Matteo
    Taurino, Ester
    Venturi, Elena
    Santini, Massimo
    [J]. MONALDI ARCHIVES FOR CHEST DISEASE, 2020, 90 (02) : 345 - 347
  • [25] Creatinine clearance and inappropriate dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation
    Yagi, Naoharu
    Suzuki, Shinya
    Arita, Takuto
    Otsuka, Takayuki
    Semba, Hiroaki
    Kano, Hiroto
    Matsuno, Shunsuke
    Kato, Yuko
    Uejima, Tokuhisa
    Oikawa, Yuji
    Yajima, Junji
    Matsuhama, Minoru
    Yamashita, Takeshi
    [J]. HEART AND VESSELS, 2020, 35 (01) : 110 - 117
  • [26] Major Bleeding in Rivaroxaban Users with Non-Valvular Atrial Fibrillation in an Older Adult Population
    Tamayo, S.
    Patel, M.
    Yuan, Z.
    Sicignano, N.
    Hopf, K.
    Peacock, F.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S221 - S221
  • [27] Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation
    Bengtson, Lindsay G. S.
    Lutsey, Pamela L.
    Chen, Lin Y.
    MacLehose, Richard F.
    Alonso, Alvaro
    [J]. JOURNAL OF CARDIOLOGY, 2017, 69 (5-6) : 868 - 876
  • [28] The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation
    Lee, Hsin-Fu
    Chan, Yi-Hsin
    Tu, Hui-Tzu
    Kuo, Chi-Tai
    Yeh, Yung-Hsin
    Chang, Shang-Hung
    Wu, Lung-Sheng
    See, Lai-Chu
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 261 : 78 - 83
  • [29] EFFICACY AND SAFETY OF RIVAROXABAN FOR NON-VALVULAR ATRIAL FIBRILLATION IN PATIENTS WITH SEVERE RENAL IMPAIRMENT
    Ali, S.
    Wakefield, L. A.
    Saja, K.
    [J]. HAEMATOLOGICA, 2016, 101 : 140 - 140
  • [30] Bleeding and Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation Treated with Apixaban or Rivaroxaban
    Abdullah, Ahmad Salihin
    Tan, Hwee Pheng
    Mohd Saffian, Shamin
    [J]. MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2022, 29 (02): : 164 - 172